Corrigendum: EGLN2 attenuates ovarian cancer malignancy via ferroptosis activation

Yue Wu1, Haiyan Chen1, Shengyuan Jiang1

  • 1Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China.

Neoplasma
|November 14, 2025
PubMed

Insights

This study corrects a previously published article DOI. The correction ensures accurate citation and referencing for future research in the field.

Area of Science:

  • This study falls within the scope of scientific publishing and research integrity.